| Literature DB >> 3532946 |
M Uwaydah, S Vartivarian, S Shatila, I Raad, H Harakeh, N T Nassar.
Abstract
Moxalactam therapy was evaluated in 25 patients with typhoid fever. A satisfactory initial response was observed in all cases. Treatment for 3 days resulted in a much higher relapse rate (three of five patients) than did treatment for 5 days (one of nine patients). None of the 11 patients treated for 10 to 11 days relapsed. Moxalactam is effective in typhoid fever, but its use is better restricted to special indications.Entities:
Mesh：
Substances：
Year: 1986 PMID： 3532946 PMCID： PMC180549 DOI： 10.1128/AAC.30.2.338
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191